title: Peritonitis during continuous ambulatory peritoneal dialysis. Treatment with pefloxacin: first results and pharmacokinetics.
authors.affiliation: Home Dialysis Unit, ALURAD, Limoges, France.
authors.forename: M
authors.initials: M
authors.lastname: Benzakour
authors.forename: C
authors.initials: C
authors.lastname: Lagarde
authors.forename: D
authors.initials: D
authors.lastname: Benevent
authors.forename: M
authors.initials: M
authors.lastname: Mounier
authors.forename: F
authors.initials: F
authors.lastname: Denis
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D015366:Pefloxacin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy
chemical_list: D015366:Pefloxacin